Clinical Trial Update: Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing imidafenacin (Uritos) to tolterodine (Urotol) for overactive bladder has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Uritos (Imidafenacin)
• Urotol (Tolterodine)

Snippet

Sponsor: R-Pharm | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2019-05-21